Tempest Therapeutics, Inc. - stock earnings
TPST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.8 million USD | ? USD |
| 2023Q2 | -7.6 million USD | ? USD |
| 2023Q1 | -8.0 million USD | ? USD |
| 2022Q4 | -10.0 million USD | ? USD |
| 2022Q3 | -9.1 million USD | ? USD |
| 2022Q2 | -9.6 million USD | ? USD |
| 2022Q1 | -8.8 million USD | ? USD |
| 2021Q4 | -7.8 million USD | ? USD |
| 2021Q3 | -8.1 million USD | ? USD |
| 2021Q2 | -7.1 million USD | ? USD |
| 2021Q1 | -5.4 million USD | ? USD |
| 2020Q4 | -4.3 million USD | ? USD |
| 2020Q3 | -5.4 million USD | ? USD |
| 2020Q2 | -5.2 million USD | ? USD |
| 2020Q1 | -12.0 million USD | ? USD |
| 2019Q4 | -12.7 million USD | ? USD |
| 2019Q3 | -11.6 million USD | ? USD |
| 2019Q2 | -9.9 million USD | ? USD |
| 2019Q1 | -6.4 million USD | 3.6 million USD |
| 2018Q3 | -5.7 million USD | 55000 USD |
| 2018Q2 | -7.7 million USD | 81000 USD |
| 2018Q1 | -7.4 million USD | 67000 USD |
| 2017Q4 | -8.5 million USD | 91000 USD |
| 2017Q3 | -9.4 million USD | 56000 USD |
| 2017Q2 | -18.2 million USD | 84000 USD |
| 2017Q1 | -14.9 million USD | 63000 USD |
| 2016Q4 | -22.6 million USD | 121000 USD |
| 2016Q3 | -19.3 million USD | 197000 USD |
| 2016Q2 | -18.6 million USD | 189000 USD |
| 2016Q1 | -21.8 million USD | 146000 USD |
| 2015Q4 | -20.6 million USD | 157000 USD |
| 2015Q3 | -17.9 million USD | 75000 USD |
| 2015Q2 | -17.5 million USD | 30000 USD |
| 2015Q1 | -17.2 million USD | 15000 USD |
| 2014Q4 | -18.9 million USD | 9.7 million USD |
| 2014Q3 | -12.9 million USD | ? USD |
| 2014Q2 | -9.9 million USD | ? USD |
| 2014Q1 | -7.8 million USD | ? USD |
| 2013Q4 | -11.0 million USD | ? USD |
| 2013Q3 | -6.9 million USD | ? USD |
| 2013Q2 | -6.0 million USD | ? USD |
| 2013Q1 | -5.2 million USD | ? USD |
| 2012Q4 | -4.2 million USD | ? USD |
| 2012Q3 | -3.1 million USD | ? USD |
| 2012Q2 | -3.2 million USD | ? USD |
| 2012Q1 | -3.0 million USD | ? USD |
| 2011Q3 | -774000 USD | ? USD |
TPST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.1 million USD | ? USD |
| 2022 | -36.8 million USD | ? USD |
| 2021 | -29.6 million USD | ? USD |
| 2020 | -19.1 million USD | ? USD |
| 2019 | -44.6 million USD | ? USD |
| 2018 | -27.2 million USD | ? USD |
| 2017 | -51.0 million USD | 295000 USD |
| 2016 | -82.3 million USD | 653000 USD |
| 2015 | -73.2 million USD | 277000 USD |
| 2014 | -49.5 million USD | 9.7 million USD |
| 2013 | -29.0 million USD | ? USD |
| 2012 | -13.5 million USD | ? USD |
TPST
Price: $3.69
52 week price:
Earnings Per Share: -1.91 USD
P/E Ratio: -1.90
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5600
Market Capitalization: 79.7 million